Sam Hirniak: Symptoms, Diagnosis, and Treatment for Women and Girls with Hemophilia
Sam Hirniak, Postdoctoral Associate at Yale School of Medicine, shared a post on LinkedIn about recent article she and her colleagues co-authored, published in Journal of Thrombosis and Haemostasis, adding:
“New paper alert.
Our recent narrative review on women and girls with hemophilia (and carriers too) is a great place to start for anyone in healthcare and/or research who is interested in learning more about this unique population.
We have included some quick reference figures on the current nomenclature, the symptoms to look out for, and the treatment options available.
Please feel free to print and share.
During this work, I learned that the first point of medical contact for heavy menstrual bleeding (the most common symptom) is often the school nurse!
So please, share this article (and the associated quick reference graphics) with anyone you know who may interact with women and girls who bleed.
Hopefully, this article will allow healthcare professionals from many distinct areas feel empowered to assist when they can and to refer when they cannot.
Many thanks to everyone involved in this review: Carla Samuel, Faria Aditi, Haya Abu-Ghazaleh, Dawn Rotellini, Menaka Pai, Andrea Edginton. Special thanks to Dawn Rotellini for providing the absolutely crucial patient and patient advocate perspective, and to Menaka Pai for the clinical perspective.
I am really proud of how we blended these perspectives together to create a wider view of the current challenges and barriers to care.
If you would like to chat further, please feel free to reach out.”
Title: Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review
Authors: Sam Hirniak, Carla Samuel, Faria Aditi, Haya Abu Ghazaleh, Dawn Rotellini, Menaka Pai, Andrea Edginton
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal